天风证券：首予康弘药业“买入”评级，目标价51.84元。

Core Viewpoint - Tianfeng Securities initiates a "Buy" rating for Kanghong Pharmaceutical with a target price of 51.84 yuan [1] Company Summary - Kanghong Pharmaceutical is recognized for its potential growth and investment value, leading to the initiation of a positive rating by Tianfeng Securities [1]